Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

649 ARTÍCULOS , VIENDO DEL 271 AL 285

Vitamin D and neurodegenerative diseases

Wang W, Li Y, Meng X.

Heliyon. 2023 Jan 12;9(1):e12877. doi: 10.1016/j.heliyon.2023.e12877. eCollection 2023 Jan.

The Endotoxin Hypothesis of Parkinson's Disease

Brown GC, Camacho M, Williams-Gray CH.

Mov Disord. 2023 Jul;38(7):1143-1155. doi: 10.1002/mds.29432. Epub 2023 May 8.

Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease"

Outeiro TF, Alcalay RN, Antonini A, Attems J, Bonifati V, Cardoso F, Chesselet MF, Hardy J, Madeo G, McKeith I, Mollenhauer B, Moore DJ, Rascol O, Schlossmacher MG, Soreq H, Stefanis L, Ferreira JJ.

Mov Disord. 2023 Jul;38(7):1127-1142. doi: 10.1002/mds.29419. Epub 2023 May 8.

The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson's Disease

Suresh K, Mattern M, Goldberg MS, Butt TR.

Neuromolecular Med. 2023 Sep;25(3):313-329. doi: 10.1007/s12017-023-08738-1. Epub 2023 Feb 5.

Focused Ultrasound Thalamotomy: Correlation of Postoperative Imaging with Neuropathological Findings

Blitz SE, Torre M, Chua MMJ, Christie SL, McDannold NJ, Cosgrove GR.

Stereotact Funct Neurosurg. 2023;101(1):60-67. doi: 10.1159/000527269. Epub 2023 Jan 25.

Prospective Long-term Follow-up of Focused Ultrasound Unilateral Subthalamotomy for Parkinson Disease

Martínez-Fernández R, Natera-Villalba E, Máñez Miró JU, Rodriguez-Rojas R, Marta Del Álamo M, Pineda-Pardo JÁ, Ammann C, Obeso I, Mata-Marín D, Hernández-Fernández F, Gasca-Salas C, Matarazzo M, Alonso-Frech F, Obeso JA.

Neurology. 2023 Mar 28;100(13):e1395-e1405. doi: 10.1212/WNL.0000000000206771. Epub 2023 Jan 11.

Parkinson's Disease Related Depression and Anxiety: A 22-Year Bibliometric Analysis (2000-2022)

Zhang T, Yang R, Pan J, Huang S.

Neuropsychiatr Dis Treat. 2023 Jun 29;19:1477-1489. doi: 10.2147/NDT.S403002. eCollection 2023.

Gene Therapy for Dopamine Dyshomeostasis: From Parkinson's to Primary Neurotransmitter Diseases

Ng J, Barral S, Waddington SN, Kurian MA.

Mov Disord. 2023 Jun;38(6):924-936. doi: 10.1002/mds.29416. Epub 2023 May 5.

Molecular mechanisms underlying the neuroprotection of environmental enrichment in Parkinson's disease

Alarcón TA, Presti-Silva SM, Simões APT, Ribeiro FM, Pires RGW.

Neural Regen Res. 2023 Jul;18(7):1450-1456. doi: 10.4103/1673-5374.360264.

Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease

Rajan S, Tryphena KP, Khan S, Vora L, Srivastava S, Singh SB, Khatri DK.

Ageing Res Rev. 2023 Jun;87:101915. doi: 10.1016/j.arr.2023.101915. Epub 2023 Mar 22.

The emerging role of circular RNAs in Parkinson's disease

Liao J, Zhang Q, Huang J, He H, Lei J, Shen Y, Wang J, Xiao Y.

Front Neurosci. 2023 Feb 16;17:1137363. doi: 10.3389/fnins.2023.1137363. eCollection 2023.

A Comprehensive Study of miRNAs in Parkinson's Disease: Diagnostics and Therapeutic Approaches

Owais S, Siddique YH.

CNS Neurol Disord Drug Targets. 2023;22(3):353-380. doi: 10.2174/1871527321666220111152756.

Novel insights into Parkin-mediated mitochondrial dysfunction and neuroinflammation in Parkinson's disease

Pereira SL, Grossmann D, Delcambre S, Hermann A, Grünewald A.

Curr Opin Neurobiol. 2023 Jun;80:102720. doi: 10.1016/j.conb.2023.102720. Epub 2023 Apr 4.

Neuromelanin: Its role in the pathogenesis of idiopathic Parkinson's disease and potential as a therapeutic target

Mitra R, Premraj L, Khoo TK.

Parkinsonism Relat Disord. 2023 Jul;112:105448. doi: 10.1016/j.parkreldis.2023.105448. Epub 2023 May 19.

The therapeutic effects of yoga in people with Parkinson's disease: a mini-review

Zhang T, Liu W, Bai Q, Gao S.

Ann Med. 2023;55(2):2294935. doi: 10.1080/07853890.2023.2294935. Epub 2023 Dec 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias